ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q907. A total of 6 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,924,610 | +58.5% | 39,100 | +70.0% | 0.00% | +100.0% |
| Q2 2023 | $4,368,620 | -42.5% | 23,000 | -39.3% | 0.00% | -66.7% |
| Q1 2023 | $7,592,128 | -53.7% | 37,900 | -45.1% | 0.00% | -62.5% |
| Q4 2022 | $16,397,850 | +17.5% | 69,000 | -1.0% | 0.01% | +33.3% |
| Q3 2022 | $13,951,000 | -55.1% | 69,700 | -67.3% | 0.01% | -53.8% |
| Q2 2022 | $31,095,000 | – | 213,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 12,500 | $1,177,000 | 0.01% |
| Timber Hill LLC | 7,700 | $725,000 | 0.00% |
| SIMPLEX TRADING, LLC | 189 | $46,000 | 0.00% |
| Citadel Advisors | 10,500 | $988,000 | 0.00% |